Cell-specific and efficient expression in mouse and human B cells by a novel hybrid immunoglobulin promoter in a lentiviral vector

被引：0
作者：
K L Laurie
M P Blundell
H E Baxendale
S J Howe
J Sinclair
W Qasim
U Brunsberg
A J Thrasher
R Holmdahl
K Gustafsson
机构：
[1] Molecular Immunology Unit,Department of Experimental Medical Science
[2] Wolfson Centre for Gene Therapy of Childhood Disease,undefined
[3] UCL Institute of Child Health,undefined
[4] Infectious Diseases and Microbiology Unit,undefined
[5] UCL Institute of Child Health,undefined
[6] Section for Medical Inflammation Research,undefined
[7] Lund University,undefined
[8] Great Ormond Street Hospital for Children NHS Trust,undefined
来源：
Gene Therapy | 2007年 / 14卷
关键词：
immunoglobulin promoter; B cells; gene transfer; EGFP;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
The expression of genes specifically in B cells is of great interest in both experimental immunology as well as in future clinical gene therapy. We have constructed a novel enhanced B cell-specific promoter (Igk-E) consisting of an immunoglobulin kappa (Igk) minimal promoter combined with an intronic enhancer sequence and a 3′ enhancer sequence from Ig genes. The Igk-E promoter was cloned into a lentiviral vector and used to control expression of enhanced green fluorescent protein (eGFP). Transduction of murine B-cell lymphoma cell lines and activated primary splenic B cells, with IgK-E-eGFP lentivirus, resulted in expression of eGFP, as analysed by flow cytometry, whereas expression in non-B cells was absent. The specificity of the promoter was further examined by transducing Lin− bone marrow with Igk-E-eGFP lentivirus and reconstituting lethally irradiated mice. After 16 weeks flow cytometry of lymphoid tissues revealed eGFP expression by CD19+ cells, but not by CD3+, CD11b+, CD11c+ or Gr-1+ cells. CD19+ cells were comprised of both marginal zone B cells and recirculating follicular B cells. Activated human peripheral mononuclear cells were also transduced with Igk-E-eGFP lentivirus under conditions of selective B-cell activation. The Igk-E promoter was able to drive expression of eGFP only in CD19+ cells, while eGFP was expressed by both spleen focus-forming virus and cytomegalovirus constitutive promoters in CD19+ and CD3+ lymphocytes. These data demonstrate that in these conditions the Igk-E promoter is cell specific and controls efficient expression of a reporter protein in mouse and human B cells in the context of a lentiviral vector.
引用
收藏
页码：1623 / 1631
页数：8
相关论文
共 165 条
  • [21] Mulligan R(1995)Regulated activity of the IgH intron enhancer (E mu) in the T lymphocyte lineage Int Immunol 7 89-813
  • [22] Gage FH(2002)High-level transduction and gene expression in hematopoietic repopulating cells using a human imunodeficiency virus type 1-based lentiviral vector containing an internal spleen focus forming virus promoter Hum Gene Ther 13 803-276
  • [23] Humeau LM(2003)Efficiency of onco-retroviral and lentiviral gene transfer into primary mouse and human B-lymphocytes is pseudotype dependent Hum Gene Ther 14 263-391
  • [24] Binder GK(2003)High-efficiency lentiviral vector-mediated gene transfer into murine macrophages and activated splenic B lymphocytes Hum Gene Ther 14 385-679
  • [25] Lu X(2004)Efficient Biochem Biophys Res Commun 318 673-89
  • [26] Slepushkin V(1981) transduction of naive murine B cells with lentiviral vectors J Clin Immunol 1 81-1316
  • [27] Merling R(2000)Pre-B cells; normal and abnormal development Blood 96 1309-672
  • [28] Echeagaray P(2000)Lentiviral-mediated gene transfer into human lymphocytes: role of HIV-1 accessory proteins Science 288 669-2187
  • [29] Bank A(2004)Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease Lancet 364 2181-554
  • [30] Dorazio R(1979)Gene therapy of X-linked severe combined immunodeficiency by use of a pseudotyped gammaretroviral vector J Immunol 122 549-148
12345678910